{
    "title": "Britain's Synairgen gets green light for coronavirus drug trial",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8127559/Britains-Synairgen-gets-green-light-coronavirus-drug-trial.html",
    "date": "2020-03-18",
    "keywords": [
        "drug",
        "disease",
        "interferonbeta",
        "paul",
        "company",
        "protein",
        "study",
        "march",
        "synairgen",
        "wednesday",
        "goahead",
        "lung",
        "function",
        "coronavirus",
        "fight",
        "trial",
        "formulation",
        "interferonbeta1a",
        "virus",
        "mechanism",
        "executive",
        "richard",
        "marsden",
        "conductor",
        "orchestra",
        "youve",
        "cold",
        "interview",
        "evidence",
        "deficiency",
        "susceptibility",
        "patient",
        "respiratory",
        "quirk",
        "production",
        "immune",
        "system",
        "asthma",
        "amount",
        "prevent",
        "cell",
        "damage",
        "replication",
        "pilot",
        "phase",
        "light",
        "healthcare",
        "agency",
        "health",
        "research",
        "authority",
        "covid19",
        "britain",
        "reporting",
        "sandle",
        "editing",
        "mark",
        "potter"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}